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A B S T R A C T
In patients with significant left ventricular (LV) dysfunction and congestive heart fail-
ure despite optimal medical therapy, implantation of cardiac resynchronization thera-
py-defibrillator (CRT-D) devices has been shown to improve symptoms and diminish 
ventricular tachyarrhythmia susceptibility. We herein describe the case of a patient 
with dilated cardiomyopathy who developed ventricular tachycardia storm (VTS) one 
month after the implantation of a CRT-D device. The storm was initially controlled 
with pharmacotherapy, allowing the patient to continue with biventricular pacing. Two 
months later the patient was readmitted due to multiple episodes of polymorphic ven-
tricular tachycardia. This time VTS was refractory to various intravenous antiarrhyth-
mic drugs and it was finally controlled only when LV pacing was turned off. In patients 
with heart failure treated with CRT-D, VTS can occur and may occasionally be best 
managed by turning off LV pacing. Our report raises an important and concerning 
issue of biventricular pacing causing ‘proarrhythmia’ in rare instances.
I N T R O D U C T I O N
Cardiac resynchronization therapy (CRT) is an established therapy of heart 
failure, especially in patients with medically refractory heart failure and evidence of 
left ventricular (LV) dyssynchrony. Multiple studies have demonstrated the benefit 
of biventricular pacing on hemodynamics, quality of life, morbidity, and mortality.1-8 
Nevertheless, electrophysiological effects of CRT are still poorly understood.
C A S E  R E P O R T
A 64-year-old Caucasian man with a history of dilated cardiomyopathy was referred 
to our department for CRT. His functional status was New York Heart Association 
(NYHA) class III on optimal medical treatment. The patient had a history of frequent 
ventricular extrasystoles along with runs of nonsustained monomorphic ventricular 
tachycardia (VT) with left bundle branch block (LBBB) morphology and inferior 
axis, i.e. positive QRS in leads II, III and aVF and negative in lead aVL on 24-hour 
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Holter monitoring or resting ECGs. Neither sustained VT 
nor syncope was previously noted. Baseline ECG showed first 
degree atrioventricular block (PR interval at 268 ms), QRS 
complex with LBBB morphology and prolonged duration (152 
ms), left axis deviation and prolonged QTc interval (536 ms, 
Fig. 1A). The patient had severe LV systolic dysfunction with 
an ejection fraction of 20%.
In view of continuing symptoms, a cardiac resynchroniza-
tion device with defibrillation capability (CRT-D) was im-
planted for primary prevention. The procedure was uneventful 
without any complications. Sensing and pacing thresholds 
were optimal. Biventricular pacing was initiated at the time 
of implantation, causing a further QTc interval prolongation 
(634 ms, Fig. 1B). Within a month post-operatively, the patient 
developed a VT storm (VTS) with multiple episodes of sponta-
neous sustained monomorphic and polymorphic VT that could 
be terminated only transiently by implantable cardioverter 
defibrillator (ICD) therapies. The majority of monomorphic 
VT episodes were interrupted with antitachycardia pacing, 
whereas most of polymorphic VT episodes were self-termi-
nated and thus, untreated (Fig. 2A). The remaining episodes 
were interrupted by ICD shocks (Fig. 2B). The diagnosis of 
both monomorphic and polymorphic VT was made using 12-
lead electrocardiography and device intracardiac electrograms 
(Fig. 2 & 3). Monomorphic VT during VTS was similar to 
the non-sustained monomorphic VT episodes before CRT-D 
implantation, i.e. with LBBB morphology and inferior axis.
The storm was initially controlled with intravenous ami-
odarone, allowing the patient to continue with biventricular 
pacing. There was no documentation of myocardial ischemia, 
metabolic or electrolyte disorders. Two months later the 
patient came to our emergency department again, complain-
ing for progressively deteriorating dyspnea and palpitations. 
Interrogation of the device showed VTS with multiple episodes 
of both monomorphic and polymorphic VT treated by anti-
tachycardia pacing or ICD shocks. Again, other than CRT-D 
FIgURE 1A. 12-lead resting ECG showing 1st degree AV block and prolonged QRS duration with LBBB morphology and left axis 
deviation. AV = atrioventricular; LBBB = left bundle branch block.
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FIgURE 1B. 12-lead resting ECG showing biventricular pacing after the CRT-device implantation. The already prolonged QTc 
interval was further increased to 634 ms after the procedure. CRT = cardiac resynchronization therapy
FIgURE 2A. Resting ECG showing self-terminating polymorphic ventricular tachycardia.
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FIgURE 2B. Intracardiac electrogram showing polymorphic VT, which degenerated into VF after the first shock delivery and it was 
finally stopped by a second shock. VF = ventricular fibrillation; VT = ventricular tachycardia
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FIgURE 3A. Resting ECG showing rapid monomorphic VT and the subsequent antitachycardia attempt by the ICD. ICD = implant-
able cardioverter defibrillator; VT = ventricular tachycardia
implantation, no readily identifiable precipitating factor for the 
VTS was elicited. The patient was managed with intravenous 
antiarrhythmic drugs (amiodarone and subsequently lido-
caine), resulting in a modest decrease in but no elimination of 
VT. Finally, LV pacing was turned off, with resolution of VT. 
All attempts to resume LV pacing resulted in VT recurrence. 
Three months after biventricular pacing was suspended, the 
patient remains in good health without any major arrhythmic 
events.
D I S C U S S I O N
Although the delayed or halted progression of cardiac 
dysfunction due to CRT may be sufficient to prevent malignant 
ventricular tachyarrhythmias, there is still lingering uncertainty 
regarding the presence and magnitude of antiarrhythmic ef-
fects of CRT per se. Furthermore, there is experimental as well 
as clinical evidence that LV pacing may have proarrhythmic 
potential. Several reports have described a ventricular proar-
rhythmia effect.9-17 It occurs frequently within the first hours 
or days after initiation of biventricular pacing. The incidence 
reported in limited single series is low, between 3.4% and 4% 
during the first few days, with a predominance in ischemic 
cardiomyopathy.11,17 Either polymorphic or monomorphic VT 
have been described. What is interesting in our case is that both 
VTs were present: episodes of nonsustained monomorphic VT 
which deteriorated after biventricular pacing and de novo ap-
pearance of polymorphic VT, apparently due to excessive QTc 
interval prolongation. Our patient received no antiarrhythmic 
medication during the time period after CRT-D implantation 
and before the first VTS. During VTS we used intravenous 
amiodarone and subsequently lidocaine. Although amiodarone 
may result in QT prolongation, it has a very low incidence of 
torsades de pointes, while lidocaine has no effect on both QT 
interval and risk of proarrhythmia. As a result, we believe that 
antiarrhythmic agents played an insignificant role in the ar-
rhythmia recurrence. It seems that QTc interval prolongation 
was entirely and solely due to biventricular pacing. Ultimately, 
the only intervention, which proved to be effective in eliminat-
ing VT episodes, was inactivation of LV pacing.
Most patients could be managed by temporary discon-
tinuation of biventricular pacing. In almost all cases, turning 
off LV pacing completely suppressed VT. Catheter ablation 
in combination with long-term antiarrhythmic medication is 
frequently proposed. Despite eliminating VT, most patients 
have a poor outcome with a low response to CRT. In our 
case, we tried, after the first VTS, to manage our patient with 
conventional intravenous antiarrhythmic therapy. Arrhythmia 
recurrence, two months later, made us abandon that idea. Only 
cessation of biventricular pacing completely suppressed VT 
and attempts to resume LV pacing resulted in VT recurrence.
There are several reported mechanisms by which biven-
tricular pacing may alter the myocardial substrate and promote 
ventricular arrhythmias. It has been found that single epicardial 
and biventricular pacing in patients with congestive heart fail-
ure increased the QT interval and the transmural dispersion 
of repolarization, creating the substrate for reentrant poly-
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morphic VT.18,19 Moreover, LV pacing significantly modifies 
the activation pattern within and around myocardial scars.12
On the other hand, there is strong evidence that cardiac 
structural and contractile reverse remodeling following CRT 
can result in a favourable antiarrhythmic effect.20,21 Specifi-
cally, Dilaveris et al demonstrated a significant improvement 
in several arrhythmogenic indices after CRT in both ischemic 
and dilated cardiomyopathy patients. Similarly, in a subanaly-
sis of MADIT-CRT trial,21 among those patients with a high 
response to biventricular pacing there was a significantly lower 
incidence of malignant ventricular tachyarrhythmias.21
C O N C L U S I O N
In line with other reports, our case raises an important 
and concerning issue of CRT causing proarrhythmia in rare 
instances. It also raises an important concern regarding the 
monitoring period after CRT device implantation, especially in 
patients receiving such a system without an ICD backup. The 
reason why certain patients go on to develop monomorphic 
or polymorphic VT after CRT therapy remains poorly under-
stood. It would be prudent for physicians to be cognizant of 
this possible proarrhythmic effect of CRT.
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